BDBM50459352 CHEMBL4217435::US10751335, Example 15

SMILES Clc1cc2[nH]c(=O)n(C3CCN(Cc4ccc(Br)cc4)CC3)c2cc1Cl

InChI Key InChIKey=MKPRNBUMJPGQCS-UHFFFAOYSA-N

Data  10 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 50459352   

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459352(CHEMBL4217435 | US10751335, Example 15)
Affinity DataEC50:  92nMAssay Description:he CisBio cAMP cell based assay kit that uses HTRF technology was utilized to assess MOR-mediated inhibition of cAMP. Assays were performed according...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459352(CHEMBL4217435 | US10751335, Example 15)
Affinity DataEC50:  129nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459352(CHEMBL4217435 | US10751335, Example 15)
Affinity DataEC50:  144nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459352(CHEMBL4217435 | US10751335, Example 15)
Affinity DataEC50:  149nMAssay Description:Agonist activity at human mu opioid receptor expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding incubated for 1 hr by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459352(CHEMBL4217435 | US10751335, Example 15)
Affinity DataEC50:  155nMAssay Description:Agonist activity at human mu opioid receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459352(CHEMBL4217435 | US10751335, Example 15)
Affinity DataEC50:  350nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459352(CHEMBL4217435 | US10751335, Example 15)
Affinity DataEC50:  501nMAssay Description:Inhibition of human mu-opioid receptor assessed as reduction in intracellular cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459352(CHEMBL4217435 | US10751335, Example 15)
Affinity DataEC50:  2.00E+3nMAssay Description:Inhibition of human mu-opioid receptor assessed as increase in beta arrestin 2 recruitmentMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459352(CHEMBL4217435 | US10751335, Example 15)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human mu opioid receptor expressed in human USOS-beta-arrestin-hMOR-PathHunter cells incubated for 90 mins by beta-arrestin-2 enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459352(CHEMBL4217435 | US10751335, Example 15)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human mu opioid receptor expressed in human U2OS cells co-transfected with beta-arrestin-2 assessed as increase in beta-arrestin-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed